Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: Possible involvement of PGE2

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 286, Issue 1 49-1, 2004, Pages

  Tanigawa, Tetsuya ^a   Watanabe, Toshio ^a   Hamaguchi, Masaki ^a   Sasaki, Eiji ^a   Tominaga, Kazunari ^a   Fujiwara, Yasuhiro ^a   Oshitani, Nobuhide ^a   Matsumoto, Takayuki ^a   Higuchi, Kazuhide ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric mucosal integrity; Neutrophil; Tumor necrosis factor

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; ISOENZYME; MESSENGER RNA; MYELOPEROXIDASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; GASTRITIS; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REGULATORY MECHANISM; STOMACH INJURY; STOMACH MUCOSA;

EID: 9144230729     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00137.2003     Document Type: Article

References (49)

1. Avunduk C, Suliman M, Gang D, Polakowski N, Eastwood GL. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate. Dig Dis Sci 36: 431-434, 1991.
2. Baatar D, Jones MK, Pai R, Kawanaka H, Szabo IL, Moon WS, Kitano S, and Tarnawski AS. Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation. Am J Pathol 160: 963-972, 2002.
3. Baik EJ, Kim EJ, Lee SH, and Moon C. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res 843: 118-129, 1999.
4. Barnett K, Bell CJ, McKnight W, Dicay M, Sharkey KA, and Wallace JL. Role of cyclooxygenase-2 in modulating gastric acid secretion in the normal and inflamed rat stomach. Am J Physiol Gastrointest Liver Physiol 279: G1292-G1297, 2000.
5. Bhang CS, Lee HS, Kim SS, Song HJ, Sung YJ, Kim JI, Chung IS, Sun HS, Park Dh, and Lee YS. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 7: 14-21, 2002.
6. Bradley PP, Priebat DA, Christensen RD, and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209, 1982.
7. Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Hui Y, Chan HL, Chan CS, Hui E, Woo J, and Sung JJ. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 359: 9-13, 2002.
8. Crabtree JE, Shallcross TM, Heatley RV, and Wyatt JI. Mucosal tumour necrosis factor-α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32: 1473-1477, 1991.
9. Dixon MF. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 201, Suppl: 7-10, 1994.
10. Feldman M, Cryer B, Mallat D, and Go MF. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. Am J Gastroenterol 96: 1751-1757, 2001.
11. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ, and Wilson KT. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116: 1319-1329, 1999.
12. Futagami S, Hiratsuka T, Wada K, Tatsuguchi A, Tsukui T, Miyake K, Akamatsu T, Hosone M, Sakamoto C, and Kobayashi M. Inhibition of Helicobacter pylori-induced cyclo-oxygenase-2 aggravates NSAID-caused gastric damage in Mongolian gerbils. Aliment Pharmacol Ther 16: 847-855, 2002.
13. Gilroy DW, Tomlinson A, and Willoughby DA. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm Res 47: 79-85, 1998.
14. Gretzer B, Ehrlich K, Maricic N, Lambrecht N, Respondek M, and Peskar BM. Cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach. Br J Pharmacol 123: 927-935, 1998.
15. Jackson LM, Wu KC, Mahida YR, Jenkins D, and Hawkey CJ. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa. Gut 47: 762-770, 2000.
16. Jones NL, Shannon PT, Cutz E, Yeger H, and Sherman PM. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 151: 1695-1703, 1997.
17. Hawkey C, Laine L, Simon T, Beaulieu A, Maldonado-Cocco J, Acevedo E, Shahane A, Quan H, Bolognese J, and Mortensen E. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group. Arthritis Rheum 43: 370-377, 2000.
18. Hudson N, Balsitis M, Filipowicz F, and Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 34: 748-751, 1993.
19. Kim JM, Kim JS, Jung HC, Song IS, and Kim CY. Apoptosis of human gastric epithelial cells via caspase-3 activation in response to Helicobacter pylori infection: possible involvement of neutrophils through tumor necrosis factor-α and soluble Fas ligands. Scand J Gastroenterol 35: 40-48, 2000.
20. Kim TI, Lee YC, Lee KH, Han JH, Chon CY, Moon YM, Kang JK, and Park IS. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity. Infect Immun 69: 5056-5063, 2001.
21. Krawisz JE, Sharon P, and Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350, 1984.
22. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263: 5380-5384, 1988.
23. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, and Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112: 1386-1397, 1997.
24. Lehmann FS, Terracciano L, Carena I, Baeriswyl C, Drewe J, Tornillo L, De Libero G, and Beglinger C. In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis. Am J Physiol Gastrointest Liver Physiol 283: G481-G488, 2002.
25. Mack Strong VE, Mackrell PJ, Concannon EM, Mestre JR, Smyth GP, Schaefer PA, Stapleton PP, and Daly JM. NS-398 treatment after trauma modifies NF-κB activation and improves survival. J Surg Res 98: 4046, 2001.
26. Masferrer JL, Koki A and Seibert K. COX2 inhibitors. A new class of antiangiogenic agents. Ann NY Acad Sci 889: 84-86, 1999.
27. Miyake K, Tsukui T, Wada K, Tatsuguchi A, Futagami S, Hiratsuka T, Shinoki K, Iizumi T, Akamatsu T, Sakamoto C, and Kobayashi M. Irritant-induced cyclooxygenase-2 is involved in the defense mechanism of the gastric mucosa in mice. J Gastroenterol 37: 164-171, 2002.
28. Mizuki I, Shimoyama T, Fukuda S, Liu Q, Nakaji S, and Munakata A. Association of gastric epithelial apoptosis with the ability of Helicobacter pylori to induce a neutrophil oxidative burst. J Med Microbiol 49: 521-524, 2000.
29. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, and Kasuga M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112: 387-397, 1997.
30. Muscara MN, McKnight W, Asfaha S, and Wallace JL. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br J Pharmacol 129: 681-686, 2000.
31. Naruse I, Keino H, and Kawarada Y. Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis. Histochemistry 101: 73-78, 1994.
32. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, and Tytgat GN. Mucosal tumor necrosis factor-α, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29: 425-429, 1994.
33. + strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 89: 863-868, 1997.
34. Publig W, Wustinger C, and Zandl C. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers. Wien Klin Wochenschr 106: 276-279, 1994.
35. Romano M, Ricci V, Memoli A, Tuccillo C, Di Popolo A, Sommi P, Acquaviva AM, Del Vecchio Blanco C, Bruni CB, and Zarrilli R. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 273: 28560-28563, 1998.
36. Santucci L, Fiorucci S, Patoia L, Di Matteo FM, Brunori PM, and Morelli A. Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sci 40: 2074-2080, 1995.
37. Shigeta J, Takahashi S, and Okabe S. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats. J Pharmacol Exp Ther 286: 1383-1390, 1998.
38. Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, and Geis GS. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA 282: 1921-1928, 1999.
39. 2 after trauma attenuates pro-inflammatory cytokines and improves survival. Shock 14: 374-379, 2000.
40. Takahashi S, Fujita T, and Yamamoto A. Role of cyclooxygenase-2 in Helicobacter pylori-induced gastritis in Mongolian gerbils. Am J Physiol Gastrointest Liver Physiol 279: G791-G798, 2000.
41. 2 of tumor necrosis factor-α and interleukin-1β production and messenger RNA expression in human monocytes stimulated by Helicobacter pylori. Dig Dis Sci 44: 2405-2411, 1999.
42. Tatsuguchi A, Sakamoto C, Wada K, Akamatsu T, Tsukui T, Miyake K, Futagami S, Kishida T, Fukuda Y, Yamanaka N, and Kobayashi M. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans. Gut 46: 782-789, 2000.
43. Tsujii M and DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
44. Wallace JL. Prostaglandins, NSAIDs, and cytoprotection. Gastroenterol Clin North Am 21: 631-641, 1992.
45. Wallace JL, Chapman K, and McKnight W. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. Br J Pharmacol 126: 1200-1204, 1999.
46. Wallace JL, McKnight W, Reuter BK, and Vergnolle N. NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119: 706-714, 2000.
47. Whittle BJ, Higgs GA, Eakins KE, Moncada S, and Vane JR. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 284: 271-273, 1980.
48. Yoshida N, Sugimoto N, Hirayama F, Nakamura Y, Ichikawa H, Naito Y, and Yoshikawa T. Helicobacter pylori infection potentiates aspirin induced gastric mucosal injury in Mongolian gerbils. Gut 50: 594-598, 2002.
49. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, and Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348-351, 1995.